Frovatriptan Succinate

  • #LGM Pharma is a Frovatriptan Succinate CAS# 158930-17-7 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 158930-17-7
  • AHFC code:
  • Synonyms: (+)-(R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide butanedioate (1:1), monohydrate, (+)-(R)-5,6,7,8-Tetrahydro-6-(methylamino)carbazole-3-carboxamide succinate (1:1), monohydrate, Frova, Frovatriptan succinate
  • ATC Code: N02CC07
  • Chemical Formula: C14-H17-N3-O.C4-H6-O4.H2-O
  • Molecular Weight: 379.4105
  • Assay/Purity: Typically NLT 98%
  • DrugBank: APRD00270
  • SMILES: CN[C,,H]1CCc2c(c3cc(ccc3[nH]2)C(=O)N)C1.C(CC(=O)O)C(=O)O.O
  • InChl: 1S/C14H17N3O.C4H6O4.H2O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8;/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8);1H2/t9-;;/m1../s1
  • PubChem: 5284561
  • IUPAC: 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-, butanedioate (1:1), monohydrate

Additional Details

Indication:
Pharmacodynamics:
Mode of Action:
Metabolism:
Toxicity:
General Reference:
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization

 

  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials